AzTrials
AzTrials

Emergency Service, HospitalNCT05126641

Analysis of Emergency Department Visits According to Incidence of Covid-19

An observational study of Emergency Service, Hospital and Epidemiology, run by Centre Hospitalier de Roubaix at 8 sites in France.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

With lockdown, Emergency Departments (ED) visits decrease, principally for visits unrelated with Covid-19. In this study, the investigators aimed to find a correlation between ED visits and incidence rate of Covid-19 in a French metropolis. Read more about this study

Who is it for?
Ages 18 years and olderHealthy volunteers can take part
Conditions the study is for
Emergency Service, Hospital, Epidemiology
How many people
400,000 participants
Where
8 sitesFrance
Study dates
13 May 2020to 4 May 2021
Phase
Observational
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • Healthy volunteers accepted
  • Adult, Older adult

Study population: All patients visited one of 9 emergency department.

Who may be able to join

  • patients over 18 years old

Who cannot join

  • patient who are transferred between centers participating to the study.

Trial locations and contacts

8 sites in 1 country.

8 sites in 1 country

France8 sites

  • Emergency Department, General Hospital

    Armentières, Nord

  • Emergency Department, General Hospital

    Hazebrouck, Nord

  • Emergency Department, University Hospital

    Lille, Nord, 59000

  • Emergency Department, GHICL Saint-Vincent

    Lille

  • Emergency Department, GHICL Saint-Philibert

    Lomme, Nord

  • Emergency Department, General Hospital

    Roubaix, Nord, 59100

  • Emergency Department, General Hospital

    Seclin, Nord

  • Emergency Department, General Hospital

    Tourcoing, Nord

Other trials in France

About this study

Official title: Analysis of Emergency Department Visits According to Incidence of Covid-19 in French Metropolis : a One-year Multicenter Observational Retrospective Study.

With lockdown, Emergency Departments (ED) visits decrease, principally for visits unrelated with Covid-19. In this study, the investigators aimed to find a correlation between ED visits and incidence rate of Covid-19 in a French metropolis.

Read the detailed description

All patients older than 18 years were included in 9 ED during 51 weeks. Patients transferred between the centers participating in the study were excluded.

The investigators count the number of visits per weeks, then the number of visits according to :

  • reason for consultation Covid-like (cough, fever or dyspnea),
  • reason for consultation with accordance to French Emergency Medicine Society (SFMU) reference
  • diagnosis with accordance to SFMU reference
  • orientation (home, medical unit, chirurgical unit, intensive care unit, psychiatric unit, death)

Pearson's correlation test compare incidence rate per week with this counts and admission rate.

Keywords
Non-Covid-19 visits, Emergency departments visits, Incidence of Covid-19
Medical subject headings
Emergencies

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. non-Covid-19 visit

    Count of non-Covid-19 visit per week

    Measured: 51 weeks

Secondary outcomes (4)

  1. Reason for visits

    Count of each reason for visits category according to SFMU reference

    Measured: 51 weeks

  2. Admission rate

    Admission rate per week

    Measured: 51 weeks

  3. Diagnosis

    Count of each diagnostic category according to SFMU reference

    Measured: 51 weeks

  4. Orientation

    Count of each orientation (home, medical unit, chirurgical unit, intensive care unit, death, psychiatric unit, other)

    Measured: 51 weeks

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted19 Nov 2021
  2. Study start13 May 2020
  3. Primary completion4 May 2021
  4. Study completion4 May 2021

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Cohort
Time perspective
Retrospective
Enrolment
400,000 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT05126641
Sponsor's protocol ID
2021-004
Other IDs
4714175, 921296
Status last verified
Nov 2021
First submitted
17 Nov 2021
Last updated
23 Nov 2021
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Publications

  • Kain T, Fowler R. Preparing intensive care for the next pandemic influenza. Crit Care. 2019 Oct 30;23(1):337. doi: 10.1186/s13054-019-2616-1.

    PubMed 31665057

  • Sivey P, McAllister R, Vally H, Burgess A, Kelly AM. Anatomy of a demand shock: Quantitative analysis of crowding in hospital emergency departments in Victoria, Australia during the 2009 influenza pandemic. PLoS One. 2019 Sep 24;14(9):e0222851. doi: 10.1371/journal.pone.0222851. eCollection 2019.

    PubMed 31550288

  • Lum ME, McMillan AJ, Brook CW, Lester R, Piers LS. Impact of pandemic (H1N1) 2009 influenza on critical care capacity in Victoria. Med J Aust. 2009 Nov 2;191(9):502-6. doi: 10.5694/j.1326-5377.2009.tb02914.x.

    PubMed 19883346

  • Schanzer DL, Schwartz B. Impact of seasonal and pandemic influenza on emergency department visits, 2003-2010, Ontario, Canada. Acad Emerg Med. 2013 Apr;20(4):388-97. doi: 10.1111/acem.12111.

    PubMed 23701347

  • Yang L, Chan KH, Suen LK, Chan KP, Wang X, Cao P, He D, Peiris JS, Wong CM. Impact of the 2009 H1N1 Pandemic on Age-Specific Epidemic Curves of Other Respiratory Viruses: A Comparison of Pre-Pandemic, Pandemic and Post-Pandemic Periods in a Subtropical City. PLoS One. 2015 Apr 30;10(4):e0125447. doi: 10.1371/journal.pone.0125447. eCollection 2015.

    PubMed 25928217

  • Kollek D. Response of a community hospital and its emergency department to the H1N1 pandemic influenza. Radiat Prot Dosimetry. 2010 Nov;142(1):12-6. doi: 10.1093/rpd/ncq271.

    PubMed 21041239

  • Kuitunen I, Ponkilainen VT, Launonen AP, Reito A, Hevonkorpi TP, Paloneva J, Mattila VM. The effect of national lockdown due to COVID-19 on emergency department visits. Scand J Trauma Resusc Emerg Med. 2020 Dec 4;28(1):114. doi: 10.1186/s13049-020-00810-0.

    PubMed 33276799

  • Boserup B, McKenney M, Elkbuli A. The impact of the COVID-19 pandemic on emergency department visits and patient safety in the United States. Am J Emerg Med. 2020 Sep;38(9):1732-1736. doi: 10.1016/j.ajem.2020.06.007. Epub 2020 Jun 6.

    PubMed 32738468

  • Westgard BC, Morgan MW, Vazquez-Benitez G, Erickson LO, Zwank MD. An Analysis of Changes in Emergency Department Visits After a State Declaration During the Time of COVID-19. Ann Emerg Med. 2020 Nov;76(5):595-601. doi: 10.1016/j.annemergmed.2020.06.019. Epub 2020 Jun 11.

    PubMed 33008651

  • Kim HS, Cruz DS, Conrardy MJ, Gandhi KR, Seltzer JA, Loftus TM, Fant AL, McCarthy DM. Emergency Department Visits for Serious Diagnoses During the COVID-19 Pandemic. Acad Emerg Med. 2020 Sep;27(9):910-913. doi: 10.1111/acem.14099. Epub 2020 Aug 17. No abstract available.

    PubMed 32737912

  • Giannouchos TV, Biskupiak J, Moss MJ, Brixner D, Andreyeva E, Ukert B. Trends in outpatient emergency department visits during the COVID-19 pandemic at a large, urban, academic hospital system. Am J Emerg Med. 2021 Feb;40:20-26. doi: 10.1016/j.ajem.2020.12.009. Epub 2020 Dec 9.

    PubMed 33338676

  • Baugh JJ, White BA, McEvoy D, Yun BJ, Brown DFM, Raja AS, Dutta S. The cases not seen: Patterns of emergency department visits and procedures in the era of COVID-19. Am J Emerg Med. 2021 Aug;46:476-481. doi: 10.1016/j.ajem.2020.10.081. Epub 2020 Nov 5.

    PubMed 33189517

  • Friedman AB, Barfield D, David G, Diller T, Gunnarson C, Liu M, Vicidomina BV, Zhang R, Zhang Y, Nigam SC. Delayed emergencies: The composition and magnitude of non-respiratory emergency department visits during the COVID-19 pandemic. J Am Coll Emerg Physicians Open. 2021 Jan 14;2(1):e12349. doi: 10.1002/emp2.12349. eCollection 2021 Feb.

    PubMed 33490998

  • Casalino E, Choquet C, Bouzid D, Peyrony O, Curac S, Revue E, Fontaine JP, Plaisance P, Chauvin A, Ghazali DA. Analysis of Emergency Department Visits and Hospital Activity during Influenza Season, COVID-19 Epidemic, and Lockdown Periods in View of Managing a Future Disaster Risk: A Multicenter Observational Study. Int J Environ Res Public Health. 2020 Nov 10;17(22):8302. doi: 10.3390/ijerph17228302.

    PubMed 33182696

  • Wongtanasarasin W, Srisawang T, Yothiya W, Phinyo P. Impact of national lockdown towards emergency department visits and admission rates during the COVID-19 pandemic in Thailand: A hospital-based study. Emerg Med Australas. 2021 Apr;33(2):316-323. doi: 10.1111/1742-6723.13666. Epub 2020 Nov 2.

    PubMed 33070468

Questions about this trial

What is this clinical trial studying?

An observational study of Emergency Service, Hospital and Epidemiology, run by Centre Hospitalier de Roubaix at 8 sites in France.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 1 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 23 Nov 2021. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 8 sites in France. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

non-Covid-19 visit (time frame: 51 weeks). It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT05126641, which also lists 20 linked publications.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 23 Nov 2021.

AzTrials uses cookies for analytics and advertising. You can accept or reject them; the site works either way. Privacy Policy.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in